Presbyopia News

The FDA approved Vizz for the treatment of presbyopia in adults, according to a press release from Lenz Therapeutics.

Vision is a uniquely personal aspect of health, and everyone can have different experiences with care.

 A second phase 3 pivotal clinical trial investigating phentolamine ophthalmic solution 0.75% for the treatment of presbyopia met its primary and key secondary endpoints, according to a press release from Opus Genetics.

Acuvue Oasys Max 1-day Multifocal for Astigmatism, the first daily disposable contact lens for people with astigmatism and presbyopia, has launched in the U.S., according to a press release from Johnson & Johnson.

The FDA accepted a new drug application for Brimochol PF for the treatment of presbyopia and set a Prescription Drug User Fee Act date of Jan. 28, 2026, according to a press release from Tenpoint Therapeutics.

SALT LAKE CITY — The thickness of the crystalline lens could be a marker for accommodative effort in presbyopic eyes, according to data presented at the Association for Research in Vision and Ophthalmology meeting.

LOS ANGELES — Patients implanted with a presbyopia-correcting IOL reported high satisfaction after surgery and preserved visual acuity in low light environments, according to a study.

Nearly 1.5 years after its approval by the FDA, Qlosi is now available for prescription in the United States, according to Orasis Pharmaceuticals.

Extended depth of focus contact lenses improved near to intermediate vision while maintaining far vision, leading to higher satisfaction in individuals with presbyopia, according to a study.